24. Purdue GF, Hunt JL. Electrocardiographic monitoring after electrical injury: necessity or luxury. J

Trauma 1986;26:166–167.

25. Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury

with thrombolytic therapy. Arch Surg 2007;142:546–551; discussion 551–553.

26. Gibran NS, Heimbach DM. Mediators in thermal injury. Semin Nephrol 1993;13:344–358.

27. Santos FX, Arroyo C, Garcia I, et al. Role of mast cells in the pathogenesis of postburn

inflammatory response: reactive oxygen species as mast cell stimulators. Burns 2000;26:145–147.

28. Zhang XJ, Irtun O, Zheng Y, et al. Methysergide reduces nonnutritive blood flow in normal and

scalded skin. Am J Physiol Endocrinol Metab 2000;278:E452–E461.

29. Garcia-Avello A, Lorente JA, Cesar-Perez J, et al. Degree of hypercoagulability and

hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res

1998;89:59–64.

30. Maass DL, White J, Horton JW. IL-1beta and IL-6 act synergistically with TNF-alpha to alter cardiac

contractile function after burn trauma. Shock 2002;18:360–366.

31. Carlson DL, Lightfoot E Jr, Bryant DD, et al. Burn plasma mediates cardiac myocyte apoptosis via

endotoxin. Am J Physiol Heart Circ Physiol 2002;282:H1907–H1914.

32. Maass DL, Hybki DP, White J, et al. The time course of cardiac NF-kappaB activation and TNFalpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac

contractile dysfunction. Shock 2002;17:293–299.

33. White DJ, Maass DL, Sanders B, et al. Cardiomyocyte intracellular calcium and cardiac dysfunction

after burn trauma. Crit Care Med 2002;30:14–22.

34. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet

2004;363:1895–1902.

35. Fagan SP, Bilodeau ML, Goverman J. Burn intensive care. Surg Clin North Am 2014;94:765–779.

36. Morio B, Irtun O, Herndon DN, et al. Propranolol decreases splanchnic triacylglycerol storage in

burn patients receiving a high-carbohydrate diet. Ann Surg 2002;236:218–225.

37. Jeschke MG, Finnerty CC, Kulp GA, et al. Combination of recombinant human growth hormone and

propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit

Care Med 2008;9:209–216.

38. Wilkins JP, Suman OE, Benjamin DA, et al. Comparison of self-reported and monitored compliance

of daily injection of human growth hormone in burned children. Burns 2003;29:697–701.

39. Ramirez RJ, Wolf SE, Herndon DN. Is there a role for growth hormone in the clinical management

of burn injuries? Growth Horm IGF Res 1998;8(suppl B):99–105.

40. Jeschke MG, Wolf SE, DebRoy MA, et al. The combination of growth hormone with hepatocyte

growth factor alters the acute phase response. Shock 1999;12:181–187.

41. Klein GL, Wolf SE, Langman CB, et al. Effects of therapy with recombinant human growth hormone

on insulin-like growth factor system components and serum levels of biochemical markers of bone

formation in children after severe burn injury. J Clin Endocrinol Metab 1998;83:21–24.

42. Herndon DN, Pierre EJ, Stokes KN, et al. Growth hormone treatment for burned children. Horm Res

1996;45(suppl 1):29–31.

43. Herndon DN, Hawkins HK, Nguyen TT, et al. Characterization of growth hormone enhanced donor

site healing in patients with large cutaneous burns. Ann Surg 1995;221:649–656; discussion 656–

659.

44. Herndon DN, Barrow RE, Kunkel KR, et al. Effects of recombinant human growth hormone on

donor-site healing in severely burned children. Ann Surg 1990;212:424–429; discussion 430–431.

45. Committee on Trauma. Excerpted from Guidelines for the Operation of Burn Centers (pp. 79–86),

Resources for Optimal Care of the Injured Patient 2006, American College of Surgeons.

http://www.ameriburn.org/BurnCenterReferralCriteria.pdf

46. Bezuhly M, Fish JS. Acute burn care. Plast Reconstr Surg 2012;130:349e–358e.

47. Branski LK, Herndon DN, Byrd JF, et al. Transpulmonary thermodilution for hemodynamic

measurements in severely burned children. Crit Care. 2011;15(2): R118. doi:10.1186/cc10147.

48. Thorne C. Grabb and Smith’s Plastic Surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.

405

http://surgerybook.net/

49. Cartotto R, Callum J. A review of the use of human albumin in burn patients. J Burn Care Res

2012;33:702–717.

50. Melinyshyn A, Callum J, Jeschke MC, et al. Albumin supplementation for hypoalbuminemia

following burns: unnecessary and costly! J Burn Care Res 2013;34:8–17.

51. Park SH, Hemmila MR, Wahl WL. Early albumin use improves mortality in difficult to resuscitate

burn patients. J Trauma Acute Care Surg 2012;73:1294–1297.

52. Graves TA, Cioffi WG, McManus WF, et al. Fluid resuscitation of infants and children with massive

thermal injury. J Trauma 1988;28:1656–1659.

53. Stawicki SP, Hoff WS, Cipolla J, et al. Use of non-invasive esophageal echo-Doppler system in the

ICU: a practical experience. J Trauma 2005;59:506–507.

54. Wang GY, Ma B, Tang HT, et al. Esophageal echo-Doppler monitoring in burn shock resuscitation:

are hemodynamic variables the critical standard guiding fluid therapy? J Trauma 2008;65:1396–

1401.